RVNC
Revance Therapeutics Inc
Price:  
3.04 
USD
Volume:  
2,736,308.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC Relative Valuation

-952.1%
Upside

As of 2024-12-12, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (25.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.04 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -952.1%.

The range of the Relative Valuation is (14.62) - (35.20) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 10.5x - 25.2x 18.5x
Forward P/E multiples 10.0x - 25.8x 18.6x
Fair Price (14.62) - (35.20) (25.91)
Upside -580.8% - -1257.9% -952.1%
3.04 USD
Stock Price
(25.91) USD
Fair Price

RVNC Relative Valuation - Historical P/E Data

Date P/E
2024-12-11 -2.18
2024-12-10 -2.17
2024-12-09 -2.17
2024-12-06 -2.74
2024-12-05 -2.83
2024-12-04 -2.99
2024-12-03 -2.81
2024-12-02 -2.67
2024-11-29 -2.59
2024-11-27 -2.71
2024-11-26 -2.88
2024-11-25 -2.72
2024-11-22 -2.67
2024-11-21 -2.75
2024-11-20 -2.72
2024-11-19 -2.70
2024-11-18 -2.86
2024-11-15 -2.99
2024-11-14 -3.09
2024-11-13 -3.04
2024-11-12 -2.96
2024-11-11 -2.47
2024-11-08 -2.65
2024-11-07 -4.14
2024-11-06 -4.17
2024-11-05 -4.19
2024-11-04 -4.17
2024-11-01 -4.16
2024-10-31 -4.23
2024-10-30 -4.24
2024-10-29 -4.24
2024-10-28 -4.23
2024-10-25 -3.37
2024-10-24 -3.80
2024-10-23 -3.79
2024-10-22 -3.79
2024-10-21 -3.79
2024-10-18 -3.79
2024-10-17 -3.71
2024-10-16 -3.79
2024-10-15 -3.73
2024-10-14 -3.69
2024-10-11 -3.79
2024-10-10 -3.77
2024-10-09 -3.76
2024-10-08 -3.74
2024-10-07 -3.82
2024-10-04 -3.74
2024-10-03 -3.77
2024-10-02 -3.72